Aspen increases revenue by 17% to R18.6 billion
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical
Filter By:
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical
Durban – United States-based Aspen Pharma USA Inc. and Aspen Global Incorporated, located in Mauritius,
Durban, South Africa – Aspen is pleased to announce that one of its wholly-owned South
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical
Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is
Aspen’s Group Treasury Team was recently recognised when they were awarded the highly acclaimed Adam
JSE listed Aspen Pharmacare Holdings Limited, Africa’s largest pharmaceutical manufacturer and the largest generic manufacturer in the southern hemisphere, has signed a non-exclusive license and
Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs Agreements with Nine Companies Will Lower Prices of HIV
JSE listed Aspen Pharmacare Holdings Limited and Lupin Limited of India have entered into an agreement to collaborate in the tuberculosis (TB) related products market
Aspen Pharmacare Holdings Limited (Aspen) has signed definitive joint venture (JV) agreements with Indian-based Matrix Laboratories Limited (Matrix). The deals strengthen Aspen’s vertical integration into
Pretoria – Aspen Pharmacare, Southern Africa’s largest generics manufacturer and JSE Securities Exchange listed pharmaceutical company, has announced the launch of Aspen-Stavudine – the first
South Africa – Boehringer Ingelheim South Africa announced today that it has granted a voluntary license to the South African pharmaceutical manufacturer Aspen Pharmacare for
East London – Bevan Gogwana, MEC for health in the Eastern Cape officially opened Aspen Pharmacare’s Oral Contraceptive manufacturing facility earlier today. Stephen Saad, Group
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com